Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: Results from a consortium study among Asians

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 7, 2012, Pages 1176-1184

  Ma, Xiangyu ^a,b   Beeghly Fadiel, Alicia ^a   Lu, Wei ^c   Shi, Jiajun ^a   Xiang, Yong Bing ^d   Cai, Qiuyin ^a   Shen, Hongbing ^e   Shen, Chen Yang ^f,g   Ren, Zefang ^h   Matsuo, Keitaro ⁱ   Khoo, Ui Soon ^j   Iwasaki, Motoki ^k   Long, Jirong ^a   Zhang, Ben ^a   Ji, Bu Tian ^l   Zheng, Ying ^c   Wang, Wenjing ^c   Hu, Zhibin ^e   Liu, Yao ^e   Wu, Pei Ei ^f   Shieh, Ya Lan ^f   Wang, Shenming ^h   Xie, Xiaoming ^m   Ito, Hidemi ⁱ   Kasuga, Yoshio ⁿ   Chan, Kelvin Y K ^j   Iwata, Hiroji ⁱ   Tsugane, Shoichiro ^k   Gao, Yu Tang ^d   Shu, Xiao Ou ^a   Moses, Harold L ^o   Zheng, Wei ^a   more..

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Shanghai Center for Disease Prevention and Control   (China)

^d SHANGHAI CANCER INSTITUTE   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

^h SUN YAT SEN UNIVERSITY   (China)

ⁱ AICHI CANCER CENTER HOSPITAL   (Japan)

^j UNIVERSITY OF HONG KONG   (Hong Kong)

^k NATIONAL CANCER CENTER   (Japan)

^l NATIONAL CANCER INSTITUTE   (United States)

^m SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

ⁿ Nagano Matsushiro General Hospital   (Japan)

^o VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ADULT; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84863572566     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0118     Document Type: Article

References (38)

1. Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 2010;10:415-24.
2. Moustakas A, Heldin CH. The regulation of TGFbeta signal transduction. Development 2009;136:3699-714.
3. Meulmeester E, Ten Dijke P. The dynamic roles of TGF-beta in cancer. J Pathol 2011;223:205-18.
4. Bottema RW, Kerkhof M, Reijmerink NE, Thijs C, Smit HA, van Schayck CP, et al. Gene-gene interaction in regulatory T-cell function in atopy and asthma development in childhood. J Allergy Clin Immunol 2010;126:338-46, 46 e1-10.
5. Tandon A, Tovey JC, Sharma A, Gupta R, Mohan RR. Role of transforming growth factor Beta in corneal function, biology and pathology. Curr Mol Med 2010;10:565-78.
6. Slattery ML, Herrick JS, Lundgreen A, Wolff RK. Genetic variation in the TGF-beta signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011;20:57-69.
7. Zheng W. Genetic polymorphisms in the transforming growth factor-beta signaling pathways and breast cancer risk and survival. Methods Mol Biol 2009;472:265-77.
8. Tang WB, Ling GH, Sun L, Liu FY. Smad anchor for receptor activation (SARA) in TGF-beta signaling. Front Biosci (Elite Ed) 2010;2:857-60.
9. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, et al. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003;63:2610-5. (Pubitemid 36605203)
10. Zhang B, Beehly-Fadiel A, Long J, Zheng W. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 2011;12: 477-88.
11. Gu D, Zhuang L, Huang H, Cao P, Wang D, Tang J, et al. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls. Breast Cancer Res Treat 2010;123: 857-61.
12. Ma X, Chen C, Xiong H, Li Y. Transforming growth factorbeta1 L10P variant plays an active role on the breast cancer susceptibility in Caucasian: evidence from 10,392 cases and 11,697 controls. Breast Cancer Res Treat 2010;124:453-7.
13. Shin A, Shu XO, Cai Q, Gao YT, Zheng W. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiol Biomarkers Prev 2005;14:1567-70. (Pubitemid 40807364)
14. Scollen S, Luccarini C, Baynes C, Driver K, Humphreys MK, Garcia- Closas M, et al. TGF-{beta} signaling pathway and breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2011;20:1112-9.
15. Woo SU, Park KH, Woo OH, Yang DS, Kim AR, Lee ES, et al. Association of a TGF-beta1 gene -509 C/T polymorphism with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010;124: 481-5.
16. Huang Y, Li B, Qian J, Xie J, Yu L. TGF-beta1 29T/C polymorphism and breast cancer risk: a meta-analysis involving 25,996 subjects. Breast Cancer Res Treat 2010;123:863-8.
17. Zheng W, Long JR, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genomewide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nature genetics 2009;41:324-8.
18. Long JR, Cai QY, Shu XO, Qu SM, Li C, Zheng Y, et al. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genetics 2010;6:e1001002.
19. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, et al. Soy food intake and breast cancer survival. JAMA 2009;302:2437-43.
20. Cai H, Xiang YB, Qu S, Long J, Cai Q, Gao J, et al. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among chinese women. Am J Epidemiol 2011;173:1263-71.
21. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123-31. (Pubitemid 41746625)
22. Ding SL, Yu JC, Chen ST, Hsu GC, Shen CY. Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2007;16:263-9.
23. Ding SL, Yu JC, Chen ST, Hsu GC, Kuo SJ, Lin YH, et al. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis 2009;30:43-9.
24. Chan KY, Liu W, Long JR, Yip SP, Chan SY, Shu XO, et al. Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women. J Med Genet 2009;46:32-9.
25. Wang Y, Hu Z, Liang J, Wang Z, Tang J, Wang S, et al. A tandemrepeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women.Carcinogenesis 2008;29:1197-201. (Pubitemid 351958699)
26. Liang J, Chen P, Hu Z, Zhou X, Chen L, Li M, et al. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 2008;29:2341-6.
27. Hamajima N, Matsuo K, Saito T, Hirose K, Inoue M, Takezaki T, et al. Gene-environment interactions and polymorphism studies of cancer risk in the hospital-based epidemiologic research program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev 2001;2: 99-107.
28. Itoh H, Iwasaki M, Hanaoka T, Kasuga Y, Yokoyama S, Onuma H, et al. Serum organochlorines and breast cancer risk in Japanese women: a case-control study. Cancer Causes Control 2009;20:567-80.
29. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-29.
30. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008;24:2938-9.
31. Gauderman W, Morrison J. QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies. Available from: http://hydra.usc.edu/gxe/. 2006.
32. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998;26:362-7. (Pubitemid 28295292)
33. Dentice M, Luongo C, Elefante A, Romino R, Ambrosio R, Vitale M, et al. Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells. Mol Cell Biol 2004;24:7863-77. (Pubitemid 39167438)
34. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006. (Pubitemid 34662293)
35. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007;447:799-816.
36. Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999;18:6938-47.
37. Lee CH, Jeon YT, Kim SH, Song YS. NF-kappaB as a potential molecular target for cancer therapy. Biofactors 2007;29: 19-35. (Pubitemid 46985299)
38. Tschan MP, Reddy VA, Ress A, Arvidsson G, Fey MF, Torbett BE. PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity. Oncogene 2008;27:3489-93. (Pubitemid 351769314)